Prof. Matthew Lungren shares his stories on how he got to where he is now and where his artificial intelligent inspiration for medicine comes from. He also talks about many great collaborations at the Stanford Center in precision medicine and what he’s looking to see more in this field in the next 5 years.
For more information, please visit https://www.TriConference.com/Precision-Medicine
All content for CHI Podcasts is the property of Cambridge Healthtech Podcasts and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Prof. Matthew Lungren shares his stories on how he got to where he is now and where his artificial intelligent inspiration for medicine comes from. He also talks about many great collaborations at the Stanford Center in precision medicine and what he’s looking to see more in this field in the next 5 years.
For more information, please visit https://www.TriConference.com/Precision-Medicine
Molecular Med TriCon 2019 | Gene Therapy for Rare Disorders
CHI Podcasts
14 minutes
5 years ago
Molecular Med TriCon 2019 | Gene Therapy for Rare Disorders
Gene therapy presents a promising path ahead for patients of rare diseases. The United States Food and Drug Administration’s Director of the Center for Biologics Evaluation and Research, Dr. Peter Marks discusses his work advancing production and availability of gene therapies for rare disorders, and the unique challenges to producing efficacious therapeutics in this field.
For more information, please visit https://www.TriConference.com/Gene-Therapy
CHI Podcasts
Prof. Matthew Lungren shares his stories on how he got to where he is now and where his artificial intelligent inspiration for medicine comes from. He also talks about many great collaborations at the Stanford Center in precision medicine and what he’s looking to see more in this field in the next 5 years.
For more information, please visit https://www.TriConference.com/Precision-Medicine
